{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:58:06Z","timestamp":1790855886505,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":2135,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1074\/jbc.m114.588087","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T02:21:08Z","timestamp":1414808468000},"page":"35826-35838","source":"Crossref","is-referenced-by-count":51,"title":["Soluble Epoxide Hydrolase as an Anti-inflammatory Target of the Thrombolytic Stroke Drug SMTP-7"],"prefix":"10.1016","volume":"289","author":[{"given":"Naoki","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Shirafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.588087_bib1","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.588087_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrneurol.2011.89","article-title":"How to make better use of thrombolytic therapy in acute ischemic stroke","volume":"7","author":"Donnan","year":"2011","journal-title":"Nat. Rev. Neurol"},{"key":"10.1074\/jbc.M114.588087_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.588087_bib4","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"IST-3 collaborative group","year":"2012","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.588087_bib5","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.588087_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/STROKEAHA.107.490375","article-title":"National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate","volume":"39","author":"Kleindorfer","year":"2008","journal-title":"Stroke"},{"key":"10.1074\/jbc.M114.588087_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0317167100004418","article-title":"TPA use for stroke in the Registry of the Canadian Stroke Network","volume":"32","author":"Nadeau","year":"2005","journal-title":"Can. J. Neurol. Sci"},{"key":"10.1074\/jbc.M114.588087_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/WCO.0b013e32832b4db3","article-title":"Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options","volume":"22","author":"Kleinig","year":"2009","journal-title":"Curr. Opin. Neurol"},{"key":"10.1074\/jbc.M114.588087_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tins.2008.09.006","article-title":"Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic","volume":"32","author":"Yepes","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1074\/jbc.M114.588087_bib10","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1111\/j.1742-4658.2010.07783.x","article-title":"Small-molecule modulators of the zymogen activation in the fibrinolytic and coagulation systems","volume":"277","author":"Hasumi","year":"2010","journal-title":"FEBS J"},{"key":"10.1074\/jbc.M114.588087_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ja.2011.108","article-title":"A new series of the SMTP plasminogen modulator with a phenylglycine-based side-chain","volume":"65","author":"Koide","year":"2012","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ja.2012.29","article-title":"A new series of the SMTP plasminogen modulators with a phenylamine-based side-chain","volume":"65","author":"Koide","year":"2012","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7164\/antibiotics.53.241","article-title":"Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure","volume":"53","author":"Hu","year":"2000","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-9560-10-2","article-title":"SMTP (Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats","volume":"10","author":"Hu","year":"2012","journal-title":"Thromb. J"},{"key":"10.1074\/jbc.M114.588087_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MBC.0000000000000032","article-title":"Mechanism of the action of SMTP-7, a novel small-molecule modulator of plasminogen activation","volume":"25","author":"Koyanagi","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1074\/jbc.M114.588087_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/STROKEAHA.110.598359","article-title":"Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion","volume":"42","author":"Miyazaki","year":"2011","journal-title":"Stroke"},{"key":"10.1074\/jbc.M114.588087_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jphs.10131FP","article-title":"A novel embolic model of cerebral infarction and evaluation of Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a novel fungal triprenyl phenol metabolite","volume":"114","author":"Hashimoto","year":"2010","journal-title":"J. Pharmacol. Sci"},{"key":"10.1074\/jbc.M114.588087_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00210-010-0542-5","article-title":"A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice","volume":"382","author":"Shibata","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol"},{"key":"10.1074\/jbc.M114.588087_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2011.08.018","article-title":"Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia\/reperfusion injury in rat brain","volume":"503","author":"Akamatsu","year":"2011","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M114.588087_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/jcbfm.2013.191","article-title":"SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates","volume":"34","author":"Sawada","year":"2014","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1074\/jbc.M114.588087_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00210-011-0642-x","article-title":"Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice","volume":"384","author":"Shibata","year":"2011","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol"},{"key":"10.1074\/jbc.M114.588087_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","article-title":"Epoxide hydrolases: their roles and interactions with lipid metabolism","volume":"44","author":"Newman","year":"2005","journal-title":"Prog. Lipid Res"},{"key":"10.1074\/jbc.M114.588087_bib23","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/bi036189j","article-title":"Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis","volume":"43","author":"Gomez","year":"2004","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.588087_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.pharmthera.2005.11.003","article-title":"From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling","volume":"111","author":"Michaelis","year":"2006","journal-title":"Pharmacol. Ther"},{"key":"10.1074\/jbc.M114.588087_bib25","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.M114.588087_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","article-title":"Epoxyeicosanoid signaling in CNS function and disease","volume":"91","author":"Iliff","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.M114.588087_bib27","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.588087_bib28","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1021\/bi050842g","article-title":"Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase","volume":"44","author":"Tran","year":"2005","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M114.588087_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.02.108","article-title":"Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids","volume":"419","author":"Morisseau","year":"2012","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.588087_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1194\/jlr.M022319","article-title":"Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase","volume":"53","author":"Oguro","year":"2012","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M114.588087_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ja.2007.60","article-title":"Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators","volume":"60","author":"Hasumi","year":"2007","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ja.2010.101","article-title":"Structure-activity relationships of 11 new congeners of the SMTP plasminogen modulator","volume":"63","author":"Hasegawa","year":"2010","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ja.2012.47","article-title":"Pre-SMTP, a key precursor for the biosynthesis of the SMTP plasminogen modulators","volume":"65","author":"Nishimura","year":"2012","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7164\/antibiotics.56.832","article-title":"SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a d-amino acid moiety","volume":"56","author":"Hu","year":"2003","journal-title":"J. Antibiot"},{"key":"10.1074\/jbc.M114.588087_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(90)90098-8","article-title":"Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53\u201378 amino acid sequence of the myelin P2 protein","volume":"30","author":"Rostami","year":"1990","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/jbc.M114.588087_bib36","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.freeradbiomed.2003.09.016","article-title":"Increased disease activity in eNOS-deficient mice in experimental colitis","volume":"35","author":"Sasaki","year":"2003","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.M114.588087_bib37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.588087_bib38","first-page":"99","article-title":"Role of animal models for the pathogenesis and treatment of inflammatory bowel disease","volume":"223","author":"Dieleman","year":"1997","journal-title":"Scand. J. Gastroenterol. Suppl"},{"key":"10.1074\/jbc.M114.588087_bib39","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest"},{"key":"10.1074\/jbc.M114.588087_bib40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.mib.0000227817.54969.5e","article-title":"Critical appraisal of the current practice in murine TNBS-induced colitis","volume":"12","author":"te Velde","year":"2006","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1074\/jbc.M114.588087_bib41","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0006-2952(02)00952-8","article-title":"Structural refinement of inhibitors of urea-based soluble epoxide hydrolases","volume":"63","author":"Morisseau","year":"2002","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.588087_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1110\/ps.051720206","article-title":"Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids","volume":"15","author":"Gomez","year":"2006","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.M114.588087_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/abbi.1995.1059","article-title":"Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis","volume":"316","author":"Zeldin","year":"1995","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M114.588087_bib44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","article-title":"Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism","volume":"163","author":"Marowsky","year":"2009","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.M114.588087_bib45","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1073\/pnas.96.19.10637","article-title":"Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase","volume":"96","author":"Argiriadi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.588087_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.prostaglandins.2012.07.005","article-title":"Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury","volume":"104","author":"Strauss","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1074\/jbc.M114.588087_bib47","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue","volume":"288","author":"Bettaieb","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.588087_bib48","doi-asserted-by":"crossref","first-page":"e11979","DOI":"10.1371\/journal.pone.0011979","article-title":"Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M114.588087_bib49","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1073\/pnas.1103482108","article-title":"Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance","volume":"108","author":"Luria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.588087_bib50","doi-asserted-by":"crossref","first-page":"e39165","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.M114.588087_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.110.167544","article-title":"Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis","volume":"334","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M114.588087_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc. Ther"},{"key":"10.1074\/jbc.M114.588087_bib53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1074\/jbc.M114.588087_bib54","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00428.2008","article-title":"Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo","volume":"295","author":"Motoki","year":"2008","journal-title":"Am. J. Physiol. Heart. Circ. Physiol"},{"key":"10.1074\/jbc.M114.588087_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/jbc.M114.588087_bib56","doi-asserted-by":"crossref","first-page":"C278","DOI":"10.1152\/ajpcell.00386.2011","article-title":"Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor","volume":"303","author":"Sanders","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.M114.588087_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of \u03c9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"10.1074\/jbc.M114.588087_bib58","first-page":"605101","article-title":"Anti-inflammatory effects of epoxyeicosatrienoic acids","volume":"2012","author":"Thomson","year":"2012","journal-title":"Int. J. Vasc. Med"},{"key":"10.1074\/jbc.M114.588087_bib59","doi-asserted-by":"crossref","first-page":"e94092","DOI":"10.1371\/journal.pone.0094092","article-title":"Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis","volume":"9","author":"Li","year":"2014","journal-title":"Plos ONE"},{"key":"10.1074\/jbc.M114.588087_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/abbi.1996.0229","article-title":"Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway","volume":"330","author":"Zeldin","year":"1996","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M114.588087_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.107.134858","article-title":"Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells","volume":"326","author":"Jiang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M114.588087_bib62","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s10620-012-2217-1","article-title":"Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10\u2212\/\u2212 mice","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig. Dis. Sci"},{"key":"10.1074\/jbc.M114.588087_bib63","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","article-title":"Soluble epoxide hydrolase: a novel therapeutic target in stroke","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1074\/jbc.M114.588087_bib64","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/STROKEAHA.107.508325","article-title":"Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"key":"10.1074\/jbc.M114.588087_bib65","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/jcbfm.2013.130","article-title":"Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus","volume":"33","author":"Jouihan","year":"2013","journal-title":"J. Cereb. Blood Flow Metab"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820579775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820579775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.588087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T06:02:27Z","timestamp":1624773747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820579775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":65,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0021925820579775"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.588087","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}